Persistence of Yellow Fever Immunization-Induced Antibodies in Allogeneic Hematopoietic Stem Cell Transplant Recipients

Affiliations

¹ Département d'hématologie, Gustave Roussy, Villejuif.
² Service de thérapie cellulaire, Gustave Roussy, Villejuif.
³ Département des soins aigus, Gustave Roussy, Villejuif.
⁴ Assistance Publique-Hôpitaux de Paris, Centre Hospitalier Universitaire de Bicêtre, Centre de vaccinations internationales, Le Kremlin-Bicêtre, France.

Comment

Marcel Adler et al. J Infect Dis. 2018.

. 2018 May 5;217(11):1844-1845.

doi: 10.1093/infdis/jiy050.

¹ Département d'hématologie, Gustave Roussy, Villejuif.
² Service de thérapie cellulaire, Gustave Roussy, Villejuif.
³ Département des soins aigus, Gustave Roussy, Villejuif.
⁴ Assistance Publique-Hôpitaux de Paris, Centre Hospitalier Universitaire de Bicêtre, Centre de vaccinations internationales, Le Kremlin-Bicêtre, France.

No abstract available

Comment in

Reply to Adler et al.
Sicre de Fontbrune F, Consigny PH. Sicre de Fontbrune F, et al. J Infect Dis. 2018 May 5;217(11):1845-1846. doi: 10.1093/infdis/jiy051. J Infect Dis. 2018. PMID: 29547947 No abstract available.

Immunogenicity and Safety of Yellow Fever Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients After Withdrawal of Immunosuppressive Therapy.
Sicre de Fontbrune F, Arnaud C, Cheminant M, Boulay A, Konopacki J, Lapusan S, Robin C, Bernaudin F, Suarez F, Simon F, Socié G, Colin de Verdière N, Consigny PH. Sicre de Fontbrune F, et al. J Infect Dis. 2018 Jan 17;217(3):494-497. doi: 10.1093/infdis/jix564. J Infect Dis. 2018. PMID: 29087520